Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 40 thumbs up ...

"It is not the BoD's job to monetize the MMP, i.e., convert the MMP asset into money. In fact, they are specifically prohibited from doing so per the Master Agreement. This is TPL's responsibility, not PTSC's."

I am reminded of Clint Eastwoods' famous line... "A mans got to know his limitations". Well if you ever read the AMD contract you would understand that this board has limitations. And it probably is good that they are not involved in any further negoiations. The shame is that they probably realize their limitations and still don't do the honorable thing. All I can say is it's a shame they are not Japanese. The problem would resolve itself.

Share
New Message
Please login to post a reply